Abstract
This chapter introduces the reader to the biopharmaceutical market sector. It discusses the history of the biopharmaceutical market and its reliance on research and development. The demand function and pricing of drugs are discussed, as well as the approval process for innovative and generic medicines in the U.S. and abroad. This is viewed within the perspectives of the healthcare and biopharmaceutical value chains.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The funding of biopharmaceutical research and development
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
